Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
YAKUODO HOLDINGS Co., Ltd. (7679.T)
JPY1,698.00
+5.00 (+0.30%)
JP JPX Healthcare Medical - Pharmaceuticals
Address
2-9-1, Morioka Station 020-0045
Morioka, JP
Morioka, JP
CEO
Tatsuhiro Saigo
Website
yakuodo-hd.co.jp
IPO
2019-09-02
ISIN JP3931410009
Description
YAKUODO HOLDINGS Co., Ltd. primarily oversees the operation of drugstores throughout Japan via its various subsidiary entities. This enterprise, established in 1978, manages a total of 358 retail locations and is officially headquartered in Morioka, Japan.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY1,698.00
+5.00 (+0.30%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
31.3K
Beta
0.08
Float Shares
9.71M
Free Float %
49.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.46% | -1.83% | -2.05% | -17.46% | -21.59% | -20.10% | -16.25% | -33.45% | -27.63% | -29.38% | -29.38% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
1,698.00
Ratings Trend (MoM)
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.80
Grey zone
Piotroski F-Score
4 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
A-
Overall Score
4 / 5
High
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Pharmaceuticals: +7.8%+7.8% ★ Q2'26: +11.7% (vs Q2'25)
-
EPS growth Medical - Pharmaceuticals: +20.2%-5.4% Q2'26: -9.7% (vs Q2'25)
-
FCF margin FCF growth · Medical - Pharmaceuticals: +43.3%+0.0% Q2'26: +0.0% (vs Q2'25)
-
EBIT margin Medical - Pharmaceuticals: +6.8%+3.4% Q2'26: +3.2% (vs Q2'25)
-
ROIC Medical - Pharmaceuticals: +6.1%+6.5% ★ Q2'26: +6.6% (vs Q2'25)
-
Share dilution Medical - Pharmaceuticals: +0.0%-0.4% ★ Q2'26: -0.7% (vs Q2'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Pharmaceuticals: 0.21×3.86× Q2'26: 2.73× (vs Q2'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Feb 2020 actual |
Feb 2021 actual |
Feb 2022 actual |
Feb 2023 actual |
Feb 2024 actual |
Feb 2025 actual |
Feb 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
102.02B
est: 101.00B (+1.0%)
|
110.54B
est: 112.00B (-1.3%)
|
120.31B
est: 119.00B (+1.1%)
|
128.79B
est: 128.00B (+0.6%)
|
142.24B
est: 142.00B (+0.2%)
|
151.96B
est: 149.00B (+2.0%)
|
158.00B
158.00B – 158.00B
+6.0% YoY
|
| EBITDA |
6.14B
est: 5.92B (+3.7%)
|
7.36B
est: 6.56B (+12.2%)
|
6.66B
est: 6.97B (-4.5%)
|
7.56B
est: 7.50B (+0.8%)
|
8.16B
est: 8.32B (-2.0%)
|
8.71B
est: 8.45B (+3.1%)
|
8.96B
8.96B – 8.96B
+6.0% YoY
|
| EBIT |
3.92B
est: 3.82B (+2.6%)
|
4.98B
est: 4.23B (+17.6%)
|
4.07B
est: 4.50B (-9.4%)
|
4.76B
est: 4.84B (-1.6%)
|
5.34B
est: 5.37B (-0.5%)
|
5.77B
est: 5.04B (+14.4%)
|
5.35B
5.35B – 5.35B
+6.0% YoY
|
| Net Income |
3.12B
est: 2.88B (+8.5%)
|
3.29B
est: 3.87B (-15.0%)
|
2.96B
est: 2.88B (+3.0%)
|
3.24B
est: 3.39B (-4.4%)
|
3.83B
est: 3.80B (+0.7%)
|
4.28B
est: 4.08B (+4.8%)
|
4.38B
4.38B – 4.38B
+7.3% YoY
|
| SGA |
16.80B
est: 16.27B (+3.2%)
|
17.72B
est: 18.05B (-1.8%)
|
19.93B
est: 19.18B (+3.9%)
|
20.79B
est: 20.63B (+0.8%)
|
22.65B
est: 22.88B (-1.0%)
|
24.18B
est: 24.04B (+0.6%)
|
25.49B
25.49B – 25.49B
+6.0% YoY
|
| EPS |
158.15
est: 146.90 (+7.7%)
|
166.66
est: 197.60 (-15.7%)
|
150.15
est: 146.90 (+2.2%)
|
164.92
est: 172.90 (-4.6%)
|
195.20
est: 193.90 (+0.7%)
|
218.17
est: 209.20 (+4.3%)
|
224.50
224.50 – 224.50
+7.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-28 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 3/5 | 4/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-17 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-15 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
3.03B
OE per share TTM
154.89
Owner's Yield
9.08%
Maintenance CapEx ratio
55.06%
Maint CapEx / Avg PPE
24.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 29 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P International Small Cap ETF GWX | 0.01% | 79.0K | 0.40% |
| 2 | Dimensional - International Small Cap ETF DFIS | 0.00% | 244.0K | 0.39% |
| 3 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.00% | 436.7K | 0.06% |
| 4 | Vanguard International Dividend Appreciation ETF VIGI | 0.00% | 179.6K | 0.07% |
| 5 | Dimensional - International Small Cap Value ETF DISV | 0.00% | 75.1K | 0.42% |
| 6 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 223.6K | 0.22% |
| 7 | iShares Core TOPIX ETF 1475.T | 0.00% | 272.9K | 0.05% |
| 8 | Dimensional International Sustainability Core 1 ETF DFSI | 0.00% | 11.1K | 0.24% |
| 9 | Vanguard FTSE Pacific ETF VPL | 0.00% | 123.5K | 0.07% |
| 10 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 85.6K | 0.28% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
5.63M
Shares Outstanding
19.45M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kiyoko Saigo | Executive Vice President, Executive Officer & Representative Director | — | male |
| Takahito Saigo | MD, Managing Executive Officer and GM of Management Strategy Division & Sales HQs and Director | — | male |
| Tatsuhiro Saigo | President & Chairperson | — | male |
| Yasuhiro Ogasawara | MD, GM of Compliance & Director | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7679.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
